Oral Tren

$68.00

  • Name: Oral Tren
  • API: Methyltrienolone
  • Dosage: 250 mcg/tab
  • Packing: 100 tabs

ORAL TREN

ORAL TREN 250 is an oral anabolic compound that provides 250 micrograms of Methyltrienolone per tablet. Methyltrienolone is the oral counterpart of Trenbolone and can be synthesized from Trenbolone Acetate. Notably, Tetrahydrogestrinone, once known for being difficult to detect in testing, is a modified derivative of Methyltrienolone.

This substance is an extremely powerful androgen with very strong anabolic activity, ranking just below Mibolerone in potency when compared milligram for milligram. It does not convert to estrogen, which means estrogen-related effects are generally not expected. ORAL TREN 250 is used for similar purposes as injectable Trenbolone, focusing on strength, muscle density, and performance enhancement.

In men, daily amounts as low as 25 micrograms can be effective, with ranges around 500 to 750 micrograms often referenced as moderate. Its strength is roughly comparable to using 150 to 225 mg of Trenbolone Acetate. Daily intake should remain under 1 mg, and use is typically limited to short periods of three to four weeks due to its intensity. Because of the high risk of virilizing effects, this compound is generally considered unsuitable for women.

Methyltrienolone is known for causing strong suppression of natural testosterone production and may significantly increase libido. It is also highly toxic to the liver, with excessive intake linked to visible signs such as yellowing of the eyes. Potential kidney strain and prostate enlargement are additional concerns. While cardiovascular issues are not commonly reported, increased aggression is frequently mentioned. Effects such as hair loss, acne, excessive body hair growth, and gynecomastia appear to be relatively uncommon. Individuals with known sensitivity to this compound should avoid its use entirely.

Reviews

There are no reviews yet.

Be the first to review “Oral Tren”

Your email address will not be published. Required fields are marked *